Galderma, the global dermatology company behind brands like Cetaphil, Differin, Restylane, and Sculptra, has chosen Miami as the new home for its U.S. headquarters. The Swiss-American firm has opened a temporary office at Brickell City Centre while searching for a permanent location nearby.
Galderma expects to base approximately 150 employees in Miami by 2028, including U.S. leadership. Heather Wallace, former CEO of Curology and Americas president for Revlon, will lead Galderma’s U.S. operations from Miami, signaling the company’s focus on growth within the competitive skincare and aesthetics industry.
Miami’s global reputation as a hub for medical aesthetics and dermatology was a major factor in the relocation. According to Galderma, the region boasts one of the nation’s highest concentrations of medical spas and dermatology clinics, with demand for aesthetic procedures growing roughly 30% annually.
CEO Flemming Ørnskov called Miami’s creativity and energy “consistent with Galderma’s ambitions” and said the city’s talent pool will be key to future success.
The move also aligns with Miami-Dade’s broader strategy to attract life sciences and healthcare firms through incentives and targeted development. Galderma’s presence further strengthens the region’s reputation as a center for innovation in consumer health and aesthetics.
Galderma will maintain operational sites in Boston, Dallas, and Carlsbad, California, but South Florida will now serve as the hub for its U.S. expansion. The company enters a skincare market projected to reach $135.8 billion globally by 2030, alongside booming demand for injectables and medical spa services.
